Probability calibration-based prediction of recurrence rate in patients with diffuse large B-cell lymphoma

BACKGROUND: Although many patients receive good prognoses with standard therapy, 30–50% of diffuse large B-cell lymphoma (DLBCL) cases may relapse after treatment. Statistical or computational intelligent models are powerful tools for assessing prognoses; however, many cannot generate accurate risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Shuanglong, Zhao, Zhiqiang, Zhang, Yanbo, Yu, Hongmei, Zheng, Chuchu, Huang, Xueqian, Yang, Zhenhuan, Xing, Meng, Lu, Qing, Luo, Yanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362168/
https://www.ncbi.nlm.nih.gov/pubmed/34389029
http://dx.doi.org/10.1186/s13040-021-00272-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362168/
https://www.ncbi.nlm.nih.gov/pubmed/34389029
http://dx.doi.org/10.1186/s13040-021-00272-9

Ejemplares similares